glp-1 intracranial hypertension Recurrent Idiopathic Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema glp 1 and intracranial hypertension
Description
Studies indicate that resistant starch and beta-glucan stimulate the intestines to release GLP-1 and peptide YY a few hours after a meal, which helps to reduce hunger between meals. Users seek plant-based protein In the ADM survey, 41% of GLP-1 users said that they were intentionally increasing their intake of plant-based proteins
An endocrinologist explains the off-label practice of microdosing weight-loss drugs, how it works, and the potential health risks
This memorandum is considered advertising under applicable state laws.
The next decade of GLP-1 innovation will look less like a straight sprint and more like a messy, multidimensional race
Effects of liraglutide on left ventricular function in patients with non-ST-segment elevation myocardial infarction
